BIBLIOGRAFÍA

1. Rao MC, Sarathy J, Sellin JH. Intestinal electrolyte absorption and secretion. In: Sleissen- ger and Fordtran's. Gastrointestinal and liver disease. 10th ed. Elsevier; 2016. Chapter 101, pp. 1713-34. [ Links ]

2. Bohn L, Storsrud S, Tornblom H, et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013;108: 634-41. [ Links ]

3. Simren M, Mansson A, Langkilde AM, et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001;63:108-15. [ Links ]

4. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel síndrome - Etiology, prevalence and consequences. Eur J Clin Nutr 2006;60:667-72. [ Links ]

5. El-Salhy M, Ostgaard H, Gundersen D, et al. The role of diet in the pathogenesis and management of irritable bowel syndrome. Int J Mol Med 2012;29:723-31. [ Links ]

6. Dapoigny M, Stockbrügger RW, Azpiroz F, et al. Role of alimentation in irritable bowel syndrome. Digestion 2003;67:225-33. [ Links ]

7. Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil 2006;18:595-607. [ Links ]

8. Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145:320-8. [ Links ]

9. Eswaran S, Goel A, Chey WD. What role does wheat play in the symptoms of irritable bowel syndrome? Gastroenterol Hepatol (NY) 2013;9:85-91. [ Links ]

10. Cenac N, Bautzova T, Le Faouder P, et al. Quantification and potential functions of endogenous agonists of transient receptor potential channels in patients with irritable bowel syndrome. Gastroenterology 2015;149: 433-44. [ Links ]

11. Wu GD, Bushmanc FD, Lewis JD. Diet, the human gut microbiota, and IBD. Anaerobe 2013;24:117-20. [ Links ]

12. Ahmed S, Macfarlane GT, Fite A, et al. Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl Environ Microbiol 2007;73:7435-42. [ Links ]

13. Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol 2014;14:667-85. [ Links ]

14. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222-7. [ Links ]

15. Zimmer J, Lange B, Frick JS, et al. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 2012;66:53-60. [ Links ]

16. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012;488:178-84. [ Links ]

17. Krishnan S, Alden N, Lee K. Pathways and functions of gut microbiota metabolism impacting host physiology. Curr Opin Biotechnol 2015;36:137-45. [ Links ]

18. Tana C, Umesaki Y, Imaoka A, et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:512-9. [ Links ]

19. Vital M, Howe AC, Tiedje JM. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio 2014;5:e00889. [ Links ]

20. Miller TL, Wolin MJ. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol 1996;62:1589-92. [ Links ]

21. Nyangale EP, Mottram DS, Gibson GR. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res 2012;11:5573-85. [ Links ]

22. Tooth D, Garsed K, Singh G, et al. Characterisation of faecal protease activity in irrita- ble bowel syndrome with diarrhoea: origin and effect of gut transit. Gut 2014;63:753-60. [ Links ]

23. Moreira AP, Texeira TF, Ferreira AB, et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 2012;108:801-9. [ Links ]

24. Simren M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159-76. [ Links ]

25. Zhu Y, Li F, Guo GL. Tissue-specific function of farnesoid X receptor in liver and intestine. Pharmacol Res 2011;63:259-65. [ Links ]

26. Porez G, Prawitt J, Gross B, et al. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J Lipid Res 2012; 53:1723-37. [ Links ]

27. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol 2010;8:159-65. [ Links ]

28. Wong BS, Camilleri M, McKinzie S, et al. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol 2011;106:2154-64. [ Links ]

29. Jones BV, Begley M, Hill C, et al. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci USA 2008;105:13580-5. [ Links ]

30. Abrahamsson H, Ostlund-Lindqvist AM, Nilsson R, et al. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation. Scand J Gastroenterol 2008;43:1483-8. [ Links ]

31. Duboc H, Rainteau D, Rajca S, et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012;24:513-20. [ Links ]

32. Shin A, Camilleri M, Vijayvargiya P, et al. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013;11:1270-5. [ Links ]

33. Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med 2017; 376:2566-78. [ Links ]

34. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91. [ Links ]

35. Cozma-Petrut A, Loghin F, Miere D, et al. Diet in irritable bowel syndrome: what to recommend, not what to forbid to patients. World J Gastroenterol 2017;23:3771-83. [ Links ]

36. Mearin F, Ciriza C, Mínguez M, et al. Clinical practice guideline: irritable bowel syndrome with constipation and functional constipation in the adult. Rev Esp Enferm Dig 2016;108:332-63. [ Links ]

37. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology 2016; 150:1393-407. [ Links ]

38. Bohn L, Storsrud S, Tornblom H, et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013;108: 634-41. [ Links ]

39. McKenzie YA, Bowyer RK, Leach H, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet 2016;29:549-75. [ Links ]

40. Portincasa P, Bonfrate L, De Bari O, et al. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf) 2017;5:11-9. [ Links ]

41. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome etiology, prevalence and consequences. Eur J Clin Nutr 2006;60:667-72. [ Links ]

42. Berg LK, Fagerli E, Myhre AO, et al. Self-reported dietary fructose intolerance in irritable bowel syndrome: proposed diagnostic criteria. World J Gastroenterol 2015;21:5677-84. [ Links ]

43. Vincenzi M, Del Ciondolo I, Pasquini E, et al. Effects of a low FODMAP diet and specific carbohydrate diet on symptoms and nutritional adequacy of patients with irritable bowel syndrome: preliminary results of a single-blinded randomized trial. J Transl Int Med 2017;5:120-6. [ Links ]

44. Makharia A, Catassi C, Makharia GK. The overlap between irritable bowel syndrome and non-celiac gluten sensitivity: a clinical dilemma. Nutrients 2015;7:10417-26. [ Links ]

45. Durchschein F, Petritsch W, Hammer HF. Diet therapy for inflammatory bowel diseas- es: the established and the new. World J Gastroenterol 2016;22:2179-94. [ Links ]

46. McKenzie YA, Bowyer RK, Leach H, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet 2016;29:549-75. [ Links ]

47. National Institute for Health and Clinical Excellence. Irritable bowel syndrome in adults: diagnosis and management. Clinical Guideline (CG61). February 2008. Last update: February 2015. Cited on January 3rd, 2017. Available from: https://www.nice.org.uk/guidance/cg61/resources/irritablebowelsyndrome-in-adults-diagnosis-and-management-975562917829 [ Links ]

48. Halmos EP. When the low FODMAP diet does not work. J Gastroenterol Hepatol 2017;1:69-72. [ Links ]

49. Harvie RM, Chisholm AW, Bisanz JE, et al. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs randomized controlled trial. World J Gastroenterol 2017;23:4632-43. [ Links ]

50. Murray K, Wilkinson-Smith V, Hoad C, et al. Differential effects of FODMAPs fermentable oligo-, di-, mono-saccharides and polyols on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol 2014;109:110-9. [ Links ]

51. Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010;31:874-82. [ Links ]

52. Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010;25: 1366-73. [ Links ]

53. McKenzie YA, Alder A, Anderson W, et al. British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet 2012;25:260-74. [ Links ]

54. Halmos EP, Power VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014;146:e5. [ Links ]

55. Staudacher HM, Lomer MC, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012;142:1510-8. [ Links ]

56. Böhn L, Störsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 2015;149:1399-407. [ Links ]

57. Pedersen N, Andersen NN, Vegh Z, et al. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol 2014;20:16215-26. [ Links ]

58. Berg LK, Fagerli E, Martinussen M, et al. Effect of fructose-reduced diet in patients with irritable bowel syndrome, and its correlation to a standard fructose breath test. Scand J Gastroenterol 2013;48:936-43. [ Links ]

59. Rao SSC, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther 2015;41:1256-70. [ Links ]

60. Hill P, Muir JG, Gibson PR. Controversies and recent developments of the low-FODMAP diet. Gastroenterol Hepatol 2017;13:36-45. [ Links ]

61. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol 2010;25:252-8. [ Links ]

62. Halmos EP, Christophersen CT, Bird AR, et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015;64:93-100. [ Links ]

63. Staudacher HM. Nutritional, microbiological and psychosocial implications of the low FODMAP diet. J Gastroenterol Hepatol 2017;32(Suppl. 1):16-9. [ Links ]

64. Parkes GC, Rayment NB, Hudpith BN, et al. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 2012;24:31-9. [ Links ]

65. Jalanka-Tuovinen J, Salonen A, Nikkilä J, et al. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One 2011;6:e23035. [ Links ]

66. Rajilic-Sotjanovic M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in faecal samples from patients with irritable bowel syndrome. Gastroenterology 2011;141:1737-801. [ Links ]

67. Deng Y, Misselwitz B, Dai N, et al. Lactose intolerance in adults: biological mechanism and dietary management. Nutrients 2015;7:8020-35. [ Links ]

68. Pal S, Woodford K, Kukuljan S, et al. Milk intolerance. Beta casein and lactose. Nutrients 2015;7:7285-97. [ Links ]

69. Crittenden RGI, Bennett LE. Cow's milk allergya: a complex disorder. J Am Coll Nutr 2005;24(Suppl 6):582S-91S. [ Links ]

70. Arroyo Villarino M, Alcedo González J. Intolerancia a la lactosa: diagnóstico y tratamiento. JANO 2004;66:956-60. [ Links ]

71. Hargrove JL, Berdanier CD. Nutrition and gene expression. Boca Raton: CRC Press; 1993. [ Links ]

72. Deng Y, Misselwitz B, Dai N, et al. Lactose intolerance in adults: biological mechanism and dietary management. Nutrients 2015;7:8020-35. [ Links ]

73. Zhu Y, Zheng X, Cong Y, et al. Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency. Am J Gastroenterol 2013;108:1516-25. [ Links ]

74. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:e4. [ Links ]

75. Fasano A, Sapone A, Zevallos V, et al. Non-celiac gluten sensitivity. Gastroenterology 2015;148:1195-204. [ Links ]

76. McKenzie YA, Bowyer RK, Leach P, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet 2016;29:549-75. [ Links ]

77. Makharia A, Catassi C, Makharia GK. The overlap between irritable bowel syndrome and non-celiac gluten sensitivity: a clinical dilemma. Nutrients 2015;10:10417-26. [ Links ]

78. Rodrigo-Sáez L, Fuentes-Álvarez D, Álvarez-Mieres N, et al. Enfermedad celiaca en el 2009. RAPD Online 2009;32:339-57. [ Links ]

79. Lucendo AJ, García-Manzanares A, Arias A, et al. Coeliac disease in the 21st century: no longer "kids' stuff". Gastroenterol Res 2011;4:268-76. [ Links ]

80. Molina-Infante J, Santolaria S, Sanders DS, et al. Systematic review: noncoeliac gluten sensitivity. Aliment Pharmacol Ther 2015;41:807-20. [ Links ]

81. Irvine AJ, Chey WD, Ford AC. Screening for celiac disease in irritable bowel syndrome: an update systematic review and meta-analysis. Am J Gastroenterol 2017;112:65-76. [ Links ]

82. Tack GJ, Verbeek WH, Schreurs MW, et al. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 2010;7:204-13. [ Links ]

83. Mooney PD, Hadjivassiliou M, Sanders DS. Coeliac disease. BMJ 2014:1561. [ Links ]

84. García-Manzanares Á, Lucendo AJ, González-Castillo S, et al. Resolution of metabolic syndrome after following a gluten free diet in an adult woman diagnosed with celiac disease. World J Gastrointest Pathophysiol 2011;15:35-60. [ Links ]

85. Molina-Infante J, Santolaria S, Montoro M, et al. Non-celiac gluten sensitivity: a critical review of current evidence. Gastroenterol Hepatol 2014;37:362-71. [ Links ]

86. Burger JP, De Brouwer B, IntHout J, et al. Systematic review with meta-analysis: dietary adherence influences normalization of health-related quality of life in coeliac disease. Clin Nutr 2017;36:399-406. [ Links ]

87. Carroccio A, Mansueto P. Response to Molina-Infante et al. Am J Gastroenterol 2013;108:451-2. [ Links ]

88. Carroccio A, Mansueto P, Iacono G, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo controlled challenge: exploring a new clinical entity. Am J Gastroenterol 2012:1898-906. [ Links ]

89. Molina-Infante J, Carroccio A. Suspected nonceliac sensitivity confirmed in few patients after gluten challnge in double-blind, placebo-controlled trials. Clin Gastroenterol Hepatol 2017;15:339-48. [ Links ]

90. Guandilini S, Polanco I. Nonceliac gluten sensitivity or wheat intolerance syndrome? J Pediatr 2015;166:805-11. [ Links ]

91. Barmeyer C, Schumann M, Meyer T, et al. Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dominant and mixed-type irritable bowel syndrome. Int J Colorectal Dis 2017;32:29-39. [ Links ]

92. Vázquez-Roque MI, Camilleri M, Smyrk T, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome diarrhea: effects on bowel frequency and intestinal function. Gastroenterology 2013;144:903-11. [ Links ]

93. Wahnschaffe U, Schulzke JD, Zeitz M, et al. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007;5:844-50. [ Links ]

94. Mujagic Z, Ludidi S, Keszthelyi D, et al. Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Aliment Pharmacol Ther 2014;40:288-97. [ Links ]

95. Fritscher-Ravens A, Schuppan D, Ellrichmann M, et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology 2014;147:1012-20. [ Links ]

96. Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145:320-8. [ Links ]

97. Vázquez-Roque MI, Camilleri M, Smyrk T, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology 2013;14:903-11. [ Links ]

98. Elli L, Tomba C, Branchi F, et al. Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: results from a multicenter randomized double-blind placebo-controlled gluten challenge. Nutrients 2016;8:84. [ Links ]

99. Zanini B, Baschè R, Ferraresi A, et al. Randomised clinical study: gluten challenge induces symptom recurrence in only a minority of patients who meet clinical criteria for non-coeliac gluten sensitivity. Aliment Pharmacol Ther 2015;42:968-76. [ Links ]

100. Di Sabatino A, Volta U, Salvatore C, et al. Small amounts of gluten in subjects with suspected nonceliac gluten sensitivity: a randomized, double-blind, placebo-controlled, cross-over trial. Clin Gastroenterol Hepatol 2015;13:1604-12. [ Links ]

101. DiGiacomo DV, Tennyson CA, Green PH, et al. Prevalence of gluten-free diet adherence among individuals without celiac disease in the USA: results from the Continuous National Health and Nutrition Examination Survey 2009-2010. Scand J Gastroenterol 2013;48:921-5. [ Links ]

102. García-Manzanares A, Lucendo AJ. Nutritional and dietary aspects of celiac disease. Nutr Clin Pract 2011;26:163-73. [ Links ]

103. Volta U, Pinto-Sánchez MI, Boschetti E, et al. Dietary triggers in irritable bowel syndrome: is there a role for gluten? J Neurogastroenterol Motil 2016;22:547-57. [ Links ]

104. Zanwar VG, Pawar SV, Gambhire PA, et al. Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded placebo controlled trial. Intest Res 2016;14:343-50. [ Links ]

105. Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 2010;123:691-3. [ Links ]

106. Volta U, De Giorgio R. New understanding of gluten sensibility. Nat Rev Gastroenterol Hepatol 2012;28:295-9. [ Links ]

107. Biesiekierski JR, Newnham ED, Irving PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 2011;106:508-14. [ Links ]

108. Shahbazkhani B, Sadeghi A, Malekzadeh R, et al. Non-celiac gluten sensitivity has narrowed the spectrum of irritable bowel syndrome: a double-blind randomized placebo-controlled trial. Nutrients 2015;7:4542-54. [ Links ]

109. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastro-intestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol 2010;25:252-8. [ Links ]

110. Catassi G, Lionetti E, Gatti S, et al. The low FODMAP diet: many question marks for a catchy acronym. Nutrients 2017;9:292. [ Links ]

111. Staudacher HM, Whelan K, Irving PM, et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011;24:487-95. [ Links ]

112. Staudacher HM, Lomer MC, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012;142:1510-8. [ Links ]

113. De Roest RH, Dobbs BR, Chapman BA, et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract 2013;67:895-903. [ Links ]

114. Halmos EP, Christophersen CT, Bird AR, et al. Diets that differ in their FODMAP content alter the colon icluminal microenvironment. Gut 2015;64:93-100. [ Links ]

115. Pedersen N, Andersen NN, Végh Z, et al. Low FODMAP diet vs. Lactobacillus-rhamnosus GG in irritable bowel syndrome. World Gastroenterol 2014;20:16215-26. [ Links ]

116. Chumpitazi BP, Cope JL, Hollister EB, et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 2015;42:418-27. [ Links ]

117. Böhn L, Störsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 2015;149:1399-407. [ Links ]

118. Whigham L, Joyce T, Harper G, et al. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J Hum Nutr Diet 2015;28:687-96. [ Links ]

119. McIntosh K, Reed DE, Schneider T, et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut 2017;66:1241-51. [ Links ]

120. Peters SL, Yao CK, Philpott H, et al. Randomised clinical trial: the efficacy of gut-directed hypnotherapyis similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:447-59. [ Links ]

121. Laatikainen R, Koskenpato J, Hongisto SM, et al. Randomised clinical trial: low FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:460-70. [ Links ]

122. Valeur J, Røseth AG, Knudsen T, et al. Fecal fermentation in irritable bowel syndrome: influence of dietary restriction of fermentable oligosaccharides, disaccharides, monosaccharides and polyols. Digestion 2016;94:50-6. [ Links ]

123. Eswaran SL, Chey WD, Han-Markey T, et al. A randomized controlled trial comparing the low FODMAP diet vs. modified NICE Guidelines in US adults with IBS-D. Am Gastroenterol 2016;111:1824-32. [ Links ]

124. Major G, Pritchard S, Murray K, et al. Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome. Gastroenterology 2017;152:124-33. [ Links ]

125. Hustoft TN, Hausken T, Ystad SO, et al. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine-profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil 2016;29:e12969. [ Links ]

126. Vici G, Belli L, Biondi M, et al. Gluten free diet and nutrient deficiencies: a review. Clin Nutr 2016;35:1236-41. [ Links ]

127. Wild D, Robins GG, Burley VJ, et al. Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet. Aliment Pharmacol Ther 2010;32:573-81. [ Links ]

128. Martínez-Barona S, Lerma JC, Fomes V, et al. Comprehensive analysis of the nutritional profile of gluten-free products compared to their gluten-free counter parts. J Pediatr Gastroenterol Nutr 2017;64(Suppl 1):741. [ Links ]

129. Lebwohl B, Cao Y, Zong G, et al. Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study. BMJ 2017;357:j1892. [ Links ]

130. Ciaccio EJ, Lewis SK, Biviano AB, et al. Cardiovascular involvement in celiac disease. World J Cardiol 2017;9:652-66. [ Links ]

131. Bulka CM, Davis MA, Karagas MR, et al. The unintended consequences of a gluten-free diet. Epidemiology 2017;28:e24-5. [ Links ]

132.